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Although  substantial  evidence suggests  that  T  cells participate  in  the  patho- 
genesis of rheumatoid arthritis (1), the mechanism(s) involved is unknown. Type 
II collagen-induced arthritis in rats (2) and mice (3) is an inflammatory synovitis, 
aspects of which  can  be passively transferred  by immunocompetent cells (4,  5) 
or IgG antibodies  (6-8).  The recognition  that  squirrel  monkeys are susceptible 
to collagen arthritis (9) has created further interest in the potential relevance of 
this  model  for  human  disease.  Rats  with  collagen  arthritis  develop  antigen- 
specific cellular sensitivity to type  II collagen,  as measured by in vitro (10-12) 
and  in  vivo  (13,  14)  assays.  This  paper  reports  the  identification  and  partial 
physicochemical characterization  of a  type II collagen-induced lymphokine that 
is arthritogenic in rats. 
Materials and  Methods 
Animals.  100-125-g  rats  from  the  following  inbred  strains  were  used  in  separate 
experiments: female Wistar-Furth (W-F) (Microbiological Associates, Walkersville, MD); 
female Louvain-MN (LOU-M) and LOU-C of either sex (Small Animal Facility, National 
Institutes of Health, Bethesda, MD); and female Listar (LIS) from a colony maintained at 
the Animal Resource Center of Harvard Medical School (Boston, MA). Histocompatibility 
in all strains was verified using mixed lymphocyte culture techniques (4,  15). Male DBA/ 
2  mice weighing  25-30  g  were purchased  from the Jackson  Laboratory (Bar Harbor, 
ME). 
Collagen.  Type II collagen, prepared by pepsin treatment of lathyritic chick sternal 
cartilage by a method previously described (2,  13), was either obtained from a commercial 
source (Genzyme Corp., Boston, MA) or purified in our laboratory. Type I collagen had 
been previously prepared (16), using pepsin, from the skin of lathyritic chicks. Collagens 
were tested for purity by amino acid analysis and disc sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) ~ (17).  Except for the portions of type II collagen 
that were thermally denatured (2), preparations were in the native state. 
Sensitization.  Sensitization was achieved by injecting rats intradermally with 0.4 mg of 
This work was supported  in part by grants AM21490, AM20850, and AI07167 from the National 
Institutes of Health, Bethesda, MD, by a Grant-in-Aid from the American Heart Association (AHA), 
with funds contributed  in part by the AHA Florida affiliate, and by grants from the New England 
Peabody Home Foundation  and the  Upjohn Company. S. Helfgott and E. Brahn are recipients of 
fellowships fiom the  Medical Research  Council of Canada,  and  from the  Arthritis  Foundation, 
respectively. Address correspondence  to S.  Helfgott,  Beth Israel Hospital YA-412, 330 Brookline 
Ave., Boston, MA 02215. 
Abbreviations used in this paper:  AF, arthritogenic  factor; BS, Blue-Sepharose; Con A, concana- 
valin A; DFP, diisopropylphosphofluoridate;  1L, interleukin; LIF, leukocyte inhibitory factor; LNC, 
lymph node cells; OD, optical density; PG, prostaglandin;  PHA, phytohemagglutinin;  SDS-PAGE, 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 
J. ExP. nED. © The Rockefeller University Press • 0022-1007/85/11/1531/15  $1.00  1531 
Volume 162  November  1985  1531-1545 1532  AN  ARTHRITOGENIC LYMPHOKINE  IN  THE  RAT 
collagen  solubilized  in  0.5  ml 0.1  M  acetic acid, and  emulsified  in  0.5  ml incomplete 
Freund's adjuvant (2), or 0.25  mg ovalbumin (grade V; Sigma Chemical Co., St.  Louis, 
MO) solubilized in 0.5 ml 0.9% NaC1 and emulsified in 0.5 ml complete Freund's adjuvant 
(12). To stimulate lymph node hypertrophy for experiments requiring nonsensitized cells, 
rats  were  injected  intradermally  with  0.5  ml  of 0.9%  NaC1  emulsified  in  0.5  ml  of 
incomplete Freund's adjuvant (12). 
Cell Preparation.  Lymph node cells (LNC) were obtained at sacrifice  14-21  d  after 
antigen injection, and subjected to Ficoll-Hypaque centrifugation to facilitate removal of 
nonviable cells (12).  Nylon wool-passaged LNC and plastic-adherent LNC (17) were used 
as sources of T  cell-enriched and monocyte/macrophage-enriched populations, respec- 
tively.  <1.5%  of the  nylon  wool-eluted  population  showed  positive  staining  using  a 
fluorescein-conjugated goat anti-rat gamma globulin (E.Y. Pharmaceuticals, San Mateo, 
CA) (18),  whereas >95%  of the plastic-adherent cells were positive by esterase staining 
(17). Type II collagen-coupled spleen cells, which are capable of inducing antigen-specific 
delayed hypersensitivity when injected subcutaneously, were prepared using ethylcarbo- 
diimide (16). 
Cultures.  LNC were cultured in Corning 25200 tubes (Corning Glass Works, Corning, 
NY) at a density of 107 cells/ml in medium 199 (Microbiological Associates), supplemented 
with penicillin-streptomycin (100  U and  100 ug/ml, respectively), buffered with 20 mM 
Hepes solution (Gibco Laboratories, Grand Island, NY), and made to contain  2% heat- 
inactivated fetal calf serum (Lot 3656; IBL Tissue Culture Products, Rockville, MD), for 
48 h at 37°C in a humidified atmosphere containing 95% air and 5% CO2 in the presence 
or absence of concentrations of concanavalin A (Con A), phytohemagglutinin-M (PHA), 
or antigen found to be optimal for the generation of rat leukocyte inhibitory factor (LIF) 
(12). T  cell- and monocyte-enriched populations were cultured under these conditions at 
densities of 107 and 105 cells/ml, respectively. Cell viability (12) exceeded 95% at culture 
onset. After 48 h, supernatants were pooled, clarified by centrifugation (12,000 g for 20 
min), dialyzed at 4°C against 0.9%  NaCl and water for an additional  48 h, and concen- 
trated to a volume of ~1.0 ml per 109 cells by vacuum dialysis or lyophilization. Vacuum- 
dialyzed material was tested immediately, and lyophilized material was stored at -20°C 
(12). 
Establishment  of Antigen-reactive  T  Cell Lines.  T  cell lines were established using the 
method of Ben-Nun et al. (19).  LOU-M or -C LNC were obtained 7-10 d postimmuni- 
zation with type II collagen or ovalbumin and suspended at a density of 5 x  106 cells/ml 
in Dulbecco's modified Eagle's medium (Microbiological Associates), supplemented with 
1% fresh rat serum, 2-mercaptoethanol (5 x  10 -5 M), penicillin-streptomycin, and Hepes. 
LNC were cultured in  100-ram petri dishes (6 ml/dish) with antigen (12).  After 72 h of 
incubation,  the  cells were harvested and  the  lymphoblasts separated  by centrifugation 
using a discontinuous Ficoll gradient (19).  A fraction containing >90% lymphoblasts was 
found consistently in the interface between densities of 1.06 and  1.05 g/ml. These cells 
were recovered by pipetting, washed twice, and cultured at a density of 2 x  105 cells/ml 
in Dulbecco's modified Eagle's medium supplemented with 20% (vol/vol) of supernatant 
containing interleukin 2 (IL-2), 10% horse serum (Gibco Laboratories), 2-mercaptoetha- 
nol,  nonessential amino acids,  sodium pyruvate, antibiotics, and  Hepes, without added 
antigen (10 ml/dish) (20).  The IL-2-containing supernatant was prepared using Con A- 
stimulated  DBA/2  splenocytes  (20).  The  isolated  lymphoblasts  that  were  propagated 
represented ~ 1% of the starting LNC population. 
After 7 d, cells  undergoing further selection were harvested and resuspended in the 
culture  medium at a  density of 2  x  10  "~ cells/ml together with  107  cells/ml irradiated 
(1,500 rad) syngeneic accessory cells (from the spleen of naive rats) and antigen (collagen 
or ovalbumin). After 72 h of incubation, the cells were collected, washed, and applied to 
a Ficoll-Hypaque gradient to isolate the viable lymphoblasts (12).  The lymphoblasts were 
resuspended in propagation culture medium (2 ×  105 cells/ml) and reseeded (10 ml/dish). 
After  3-4  d  of incubation,  the  cells were  harvested and  restimulated  with  antigen  as 
described above. Supernatants used in this study were collected on either day 20 or 56, 
which  was at the  end  of an antigen-stimulation cycle. T  cell  membrane markers were HELFGOTT  ET  AL.  1533 
identified as described (18),  using the murine monoclonals, W3/13,  W3/25,  and OX8 
(Accurate  Chemical  and  Scientific  Corp.,  Westbury,  NY)  and  fluorescein-conjugated 
F(ab')2 fragments of goat anti-mouse lgG (Fc fragment-specific) (Cappel Laboratories, 
Cochranville, PA). 
Thymidine  Incorporation  Assay.  Proliferation  responses  of line  cells  to  Con  A  and 
antigen stimulation were measured by a thymidine incorporation technique adapted from 
one used previously (10,  13).  Line cells were  incubated in  round-bottomed microtiter 
plates in quadruplicate wells.  Each well contained 2.5 X  104 cells plus 106 accessory cells 
consisting of irradiated (1,500 rad) syngeneic spleen cells in 0.2 ml Dulbecco's modified 
Eagle's medium with  1% fresh rat serum in the presence or absence of antigen/mitogen 
at described concentrations (12,  13).  After 48  h  of incubation,  cells in each welt were 
pulsed with 1 uCi [SH]thymidine (sp act, 5.0 Ci/mM; Amersham Corp., Arlington Heights, 
IL), and incorporation was measured 18 h later (21). Results are expressed as a stimulation 
index,  calculated as (mean cpm with antigen  or Con A)/(mean cpm without antigen or 
mitogen). 
Gel  Filtration.  Lyophilized  supernatant  material  was  fractionated  on  a  calibrated 
column (2.5 ×  100 cm) containing Sephadex G-100 (Pharmacia Fine Chemicals, Piscata- 
way, N  J) and was subsequently processed as described (12). 
Affinity  Chromatography.  Supernatant  material,  derived  from serum-containing cul- 
tures of nylon wool-purified cells or line cells, was depleted of albumin using the method 
of Travis et al. (22).  40 mg of lyophilized crude supernatant material was solubilized in 
0.05 M Tris-HC1 with 0.1  M KCI, pH 7.0, and applied to a preequilibrated 0.9 x  30 cm 
column containing Blue-Sepharose CL-6B (BS) (Pbarmacia Fine Chemicals). Fractions of 
unbound material with an optical density at 280 nm (OD2s0) of >0.05  were pooled (BS 
peak I). Bound material, including albumin, was eluted with 0.05 M Tris-HC1 and 0.2 M 
NaSCN, pH 8.0 (BS peak II). Both pools were vacuum dialyzed to about one twentieth 
their original volume. Depletion efficiency was assessed by radial immunodiffusion, using 
1.5% agarose containing a  1:50 dilution of rabbit anti-horse albumin (Cappel Laborato- 
ries) or rabbit anti-bovine albumin (Cappel Laboratories), where appropriate. Up to 96% 
of the albumin was removed from BS peak I by this procedure. 
For the final affinity isolation, collagen was linked to CNBr-activated Sepharose 4  B 
(Pharmacia Fine Chemicals), using the method of Stuart et al. (6).  Once the ligand (type 
1 or II collagen) had been bound and the gel reequilibrated with the coupling buffer (0.01 
M phosphate-buffered saline with 0.5 M NaCl), 4 ml of BS peak I in phosphate-buffered 
saline was added to the gel and incubated overnight at 4°C with rocking. A  1 x  6  cm 
column was filled with the gel, washed with phosphate-buffered saline until the OD280 was 
<0.01, and fractions were pooled (CNBr peak I). A 0.2 M glycine-HC1 wash, pH 2.8, was 
pumped onto the  column and  allowed to remain  for 3  h  before eluting.  These  latter 
fractions were also pooled (CNBr peak II). Elution profiles were monitored at OD2s0 and 
concentrations  determined  by the  Bio-Rad protein  assay (Bio-Rad  Laboratories, Rich- 
mond, CA), with bovine serum albumin as a standard (23).  Both pools were dialyzed for 
48 h against distilled water, lyophilized, and stored at -20°C. 
SDS-PAGE.  Discontinuous SDS-PAGE was performed as described by Laemmli (24). 
All samples were run under reduced conditions using 2-mercaptoethanol. 10% polyacryl- 
amide,  1.5-mm-thick  slab  gels  were  stained  by a  silver  nitrate  method,  which  detects 
quantities of protein of ~ 10 ng (25). Relative molecular weight (Mr) was determined using 
the following Bio-Rad protein standards: phosphorylase b (92,500), bovine serum albumin 
(66,200),  ovalbumin  (50,000  and  45,000),  carbonic  anhydrase  (31,000),  and  soybean 
trypsin inhibitor (21,500). 
lmmunoglobulin  Preparation.  Material  enriched  for Ig was prepared by ammonium 
sulfat  e  precipitation  (16)  of pooled  serum,  obtained  at  sacrifice  from  the  rats  that 
developed collagen arthritis,  or from immunoiogically naive rats, and stored at -20°C. 
The  IgG antibody titer  to  nativ  e  type  II collagen was measured  by an enzyme-linked 
immunosorbent assay (26). 
Intraarticular  Injections.  Crude  or  G-100-fractionated  supernatant  and  lg-enriched 
material were resuspended in  Hanks' balanced salt solution (Microbiological Associates) 1534  AN  ARTHRITOGENIC  LYMPHOKINE  IN  THE  RAT 
at a  ratio of 1 :I  (vol/vol).  Protein  concentrations  of the crude  supernatants  were ~700 
mg-percent,  as  measured  by  the  Lowry  technique  (27).  Affinity-purified  supernatant 
material was resuspended  in Hanks' balanced salt solution at a concentration of ~<10 mg- 
percent protein.  Suspensions were membrane (0.45  ~tm)-sterilized.  Under aseptic condi- 
tions, 200 ~tl of the crude or G-100 suspension was injected through the avascular region 
of the infrapatellar ligament (28) into one knee ofa syngeneic naive rat, lightly anesthetized 
with ether, using a 26-gauge needle. For affinity-purified supernatants,  100 ul was injected. 
Arthritis Assessments.  After knee injection, rats were evaluated at least every other day 
for overt clinical signs of arthritis, i.e., a limping gait or obvious knee-joint swelling. Unless 
specified, rats were sacrificed 7 d postinjection.  Synovial tissue overlying the infrapatellar 
fat pad and the contiguous margins of the patellar and/or  tibial cartilage were removed 
and blocked in paraffin; multiple 5-7-t~m-thick sections were obtained and either stained 
with  hematoxylin  and  eosin,  or  processed  for  immunofluorescence  (28).  Based  upon 
morphologic studies in collagen arthritis (2, 4, 28,  29), and a method used by Andreis et 
al. (30) in a rabbit-synovitis model, a scoring system was devised for the hematoxylin and 
eosin-stained slides to reflect (a) the magnitude of diffuse synovial membrane thickening 
(<5 cell layers thick -- 0; 5-10 cell layers =  1;  10-15 cell layers =  2; >15 cell layers =  3), 
and  (b)  the  degree  of  inflammatory  cell  (mononuclear  cells  and  polymorphonuclear 
leukocytes)  infiltration  and  neovascularization  in  the  subsynovial  layers  (absent  --  0; 
minimal  --  1;  moderate  =  2;  marked  --  3).  Each  of the  two categories  was assigned  an 
integer,  resulting  in  a  maximum  histologic  score  of six.  Slides  were  read  by the  same 
observer,  who was unaware of the experimental  group  from which  the tissue  had been 
obtained; at least five sections were evaluated from each knee. 
Physicochemical Treatments.  G-100-fractionated  supernatant  material  was exposed  to 
heat,  chymotrypsin  (a  proteinase  with  broad  specificities),  and  to  the  serine  esterase 
inhibitor,  diisopropylphosphofluoridate  (DFP) under conditions previously used to char- 
acterize rat LIF (12). In other experiments,  LNC from arthritic rats were cultured in the 
presence or absence of the endotoxin  inactivator,  polymyxin B (5 ug/ml) (17), or puro- 
mycin, which  was used at a  nonlethal  concentration  to block de novo protein  synthesis, 
and removed by methods already described (12). 
L1F Assay.  LIF activity in G-100-fractionated  material was measured  by its ability to 
inhibit the migration  of rat polymorphonuclear leukocytes from capillary tubes. Activity 
generated by Con A provided a control (12). 
Complement Depletion.  Cobra venom factor was prepared and analyzed by the method 
of Salant et al.  (31).  Rats were injected  intraperitoneally  with  75  and  25  U  (32)  cobra 
venom factor on day -1 and day 4, respectively, and intraarticularly  with G-100-fraction- 
ated  material on day 0.  Serum C3,  measured  by Mancini  single radial  immunodiffusion 
(33), was undetectable in all of the rats on day 4, and was <45% of the pretreatment value 
on day 7, when the rats were sacrificed. 
Statistical  Analyses.  Continuous  variables were  analyzed  by their  group  means  (Stu- 
dent's t-test) and dichotomous variables by their proportionate group frequencies (×2 test). 
Results 
Identification  of Arthritogenic  Factor (AF).  As  shown  in  Table  I, a  significant 
synovitis  developed  in  the  injected  knees  of  W-F  rats  receiving  the  crude 
supernatant  material  from  cultures  of LNC  or  T  cells  from  collagen-arthritic 
rats  stimulated  in  vitro  with  native  type  II  collagen.  Although  ovalbumin  is  a 
potent  cellular  immunogen  in  rats  (12,  16),  injection  of supernatants  derived 
from ovalbumin-sensitized  LNC  did not create this lesion.  Only minimal inflam- 
mation  developed  following  injection  of  Ig  containing  antibodies  to  type  II 
collagen.  The  inability of collagen-coupled  cells,  as well as supernatants  derived 
by culturing  LNC  from  nonartbritic  cells or  macrophage-enriched  cell  popula- 
tions  with  native  type  II collagen,  to  induce  appreciable  synovitis  suggests  that 
collagen  carryover does not explain  the results of these experiments. HELFGOTT  ET  AL.  1535 
TABLE  I 
Histologic Assessment of Synovial and Subsynovial  Tissue in Knees from W-F Rats Injected 
with Crude Supernatant or Serum-derived  Material 
Culture 
Amigen  Donor*  Material injected  Histologic score 
Cell  Stimulus  (n)*  P 
Type II  Arthritic  LNC  Type 11  Supernatant  3.9 +- 0.5  t (14)  I  -- 
Type II  Arthritic  LNC  Denatured  type  Supernatant  2.0-+ 0.6  (8)  0.031 
It 
Type II  Nonarthritic  LNC  Type II  Supernatant  1.6 +  0.3  (10)  0.002  ~ 
Type 1  Nonarthritic  LNC  Type I  Supernatant  1.7 4- 0.3  (10)  0.003  ~ 
Type tl  Arthritic  LNC  Con A  Supernatant  0.7 _+ 0.7  (7)  0.00011 
Type II  Arthritic  LNC  PHA  Supernatant  1.5 +  0.5  (4)  0.031 
Type II  Arthritic  T  cell  Type [1  Supernatant**  3.5 4. 0.6  (6)  ~  -- 
Ovalbulnin  Nonarthritic  T  cell  Ovalbumin  Supernatant**  1.5 4. 0.3  (4)  0.05  II 
Type II  Arthritic  Macrophage  Type II  Supernatant II  1.2"4-0.5  (4)  0.02  H 
....  Type II-coupled cells  ~  1.5 4. 0.5  (4)  0.03  H 
....  Arthritic serum fraction***  2.1 4- 0.4  (8)  0.031 
....  Nonarthritic serum fraction  ~  2.0 4- 0.3  (6)  0.03  ! 
....  Nonimmune  serum fraction  1,2 4- 0.6  (5)  0.011 
....  Hanks' balanced salt solution  0.4 4- 0.4  (5}  0.0011 
* 70% of the rats  developed arthritis 10-16 d  after immunization  with native type 11 collagen. In these and previous experiments 
(2,  10), no arthritis resulted when rats were immunized with the other antigens. 
:~ n  represents the number of rats in which the injected knee was evaluated. 
{I Histologic scores are given as mean +  SEM for each group. 
I One ral developed limping and swelling of the knee. 
I Significance compared  to the score produced  by the supernatant  from the arthritic LNC cultured with type II collagen. 
** Knees received material derived from  108 nylon wool-purified cells. 
~: Two rats developed  limping and swelling of the  knee.  Except  for those  mentioned,  none  of the other injected  knees  in  these 
experiments exhibited clinical signs of arthritis. 
~l Significance compared to the score produced by the supernatant from the arthritic T  cells cultured with type l] collagen. 
II Knees received material derived from  2.5 x  l0  s plastic-adherent cells. 
!~ 5  x  107 cells in Hanks' balanced salt solution injected. 
***  IgG antibody titer,  12 serial twofold dilutions. 
Antibody  titer, eight serial twofold dilutions. 
To estimate the molecular mass of the lymphokine responsible for this inflam- 
matory activity, lyophilized material from arthritic W-F LNC cultured with type 
I I collagen underwent Sephadex G-100 filtration. The eluate from  10 columns 
was divided into three fractions (high molecular mass fraction, 90-60 kilodaltons 
[kD];  intermediate  fraction,  60-23  kD;  and  low molecular mass fraction, <23 
kD). 9 (41%) of 22 rats injected with the high fraction, vs.  1 of 15 rats injected 
with  the  intermediate  fraction,  and  none  of  18  rats  injected  with  the  low 
molecular mass fraction developed overt clinical signs of knee arthritis (P <  0.01 
for both comparisons) (Fig.  1).  The mean histologic score of rats injected with 
the high-mass fraction was significantly greater than the scores of the other two 
groups (Table  II).  Additional  subfractionation  of G-100-derived  material  indi- 
cated that AF activity eluted in the 60-70  kD range.  Other studies depicted in 
Table lI showed that AF was an in vitro-synthesized protein, distinct from the 
similarly sized iymphokine,  LIF (12),  and not inactivated  at  56°C;  its arthrito- 
genicity was not  likely to be due  to contamination  by endotoxin.  Complement 
depletion with cobra venom factor did not affect the response of rats to AF. 
Affinity Pur~cation  of AF.  The inability of mitogens and antigens other than 
native type II collagen to generate arthritogenic supernatants (Table I) suggested 
that  AF  is  an  antigen-specific  lymphokine.  Accordingly,  W3/25 + T  cell  lines 
were established from collagen-immunized LOU-M and LOU-C rats that reacted 1536  AN  ARTHRITOGENIC LYMPHOKINE IN  THE  RAT 
FIGURE  1.  Swollen  knee (viewer's right) 7 d after injection  of G-100-enriched AF, compared 
to the uninjected  knee, of a sacrificed  rat in which the overlying  skin has been reflected. 
specifically to type II collagen (Table III). The LOU strain was selected because 
of its high degree of susceptibility to collagen arthritis observed in other (unpub- 
lished) studies.  An  additional W3/25 + line was  established from  LOU-M  rats 
immunized with ovalbumin and CFA by stimulation with ovalbumin; this line 
reacted to antigenic challenge with both ovalbumin and mycobacteria. 
The  supernatant  materials  derived  from  these cell  lines  were  used  in  the 
following affinity chromatography studies. The two collagen-reactive T  cell lines 
produced  material  that  bound  to  type  II  collagen,  and  when  eluted,  gave 
pronounced AF responses in the knee assay (Table IV). This antigen-binding AF 
activity was  also  generated  by  nylon  wool-nonadberent  cells  obtained  from 
arthritic W-F and LIS rats. No binding occurred when this material was passaged 
through  an  affinity  column  prepared  with  type  I  collagen.  The  ovalbu- 
min/mycobacteria-reactive line did not produce collagen-binding AF activity. 
Material enriched for lymphokines by stimulating naive nylon wool-nonadherent 
cells with Con A and subjecting the supernatant to attempted affinity purification 
on the type I!  collagen column was also devoid of AF activity. This result, as 
well as  the outcome of the ovaibumin/mycobacteria line experiment, make it 
unlikely that collagen leached off the affinity column produced the inflammation 
in these studies. 
SDS-PAGE under reducing conditions showed a single protein band in tile T 
cell-derived AF containing materials eluting from the type II collagen-Sepharose 
column (Fig.  2).  Similar to the  molecular mass estimates by gel  filtration, the HE1,FGOTT  ET  AL.  1537 
TABLE  II 
Studies of Rat AF in W-F Rats 
Material tested  Histologic score  p 
(n) 
Fractionated AF (kD) 
60-90  3.8 +  0.5 (22)*  -- 
23-60  1.8 -  0.4 (15)*  0.01 
<23  1.1  _+ 0.2 (18)  0.001 
60-70  2.8 +  0.3 (11)*  -- 
50-60  2.0 +  0.4 (8)  NS  § 
70-80  1.0 +  0.3 (11)  0.0001 
80-90  0.7+0.3(11)  0.001 
Normal recipient 
Complement-depleted recipient 
2.9 -+ 0.5 (7)  -- 
2.8 __ 0.8 (4)  NS 
Incubation without chymotrypsin 
Incubation with chymotrypsin 
2.9 +- 0.5 (7)  -- 
0.7 _+ 0.3 (3)  0.02 
Incubation without DFP  2.0 +- 1.0 (2)  -- 
Incubation with DFP !  2.0 -  0.0 (2)  NS 
No heat  2.2 -  0.5 (4)  -- 
Heat (56°C, 30 rain)  2.0 +- 0.6 (5)  NS 
Heat (80°C, 30 rain)  0.6 +  0.6 (5)  NS 
Unfractionated material  ~ 
No drug  3.9 +  0.5 (14)*  -- 
Polymyxin B  3.5 +  0,6 (4)  NS 
Puromycin  1.7 +  0.5 (4)  0.05 
Designations are identical to those described in Table I. 
* Nine rats developed limping and swelling of the knee. 
* One rat developed limping and swelling of the knee. Except for those 
mentioned,  none  of  the  other  injected  knees  in  these  experiments 
exhibited clinical signs of arthritis. 
NS, not significant. 
IL The resistance of AF to DFP indicates that, unlike rat LIF, this protein 
is not a serine esterase (12).  In addition, this fractionated AF preparation 
did not possess  LIF activity (mean migration inhibition was 8% vs. 54% 
for AF and Con A-induced LIF, respectively). 
q Obtained by culturing arthritic  LNC with type II collagen in the pres- 
ence or absence of a drug. 
affinity-purified  AF  from  the  T  cell  lines  and  the  nylon  wool-purified  T  cell 
populations  possessed  an M,- of 65,000  by SDS-PAGE. 
Characteristics of Lesion Induced by AF.  Pannus  formation,  neovascularization, 
and  synovial  infiltrates,  consisting  predominantly  of mononuclear  inflammatory 
cells, some  polymorphonuclear  leukocytes,  and  a  few eosinophils,  were  found  as 
early  as  48  h  after  injection  of G-100-enriched  AF  into  the  knees  of W-F  rats. 
Cartilage  erosion  was also noted  at this time  (Fig.  3).  Granulomatous  areas  were 
occasionally observed  in the pannus  of day 7  lesions induced  with G-100-enriched 
AF,  and  immunofluorescence  evaluation  of  synovia  during  the  period  2-7  d 1538  AN  ARTHRITOGENIC  LYMPHOK1NE  IN  THE  RAT 
TABLE  III 
Thymidine Incorporation Responses by T Cell Lines 
Stimulation index with antigen or mitogen 
Propagating  Background  Myco- 
Strain  antigen  (cpm)  Type II  Type I  Oval-  PPD*  bacte-  Con A 
collagen  collagen  bmnin  ria 
LOU-M  Type 11  398 --- 97  16.8  0.7  0.8  0.4  ND  7.8 
I.OU-C  Type 1I  199 +  16  1.5  ND  ND  0.9  ND  1.3 
LOU-M  Ovalbumin  15,772  +  830~  1.1  ND  2.4  1.2  2.0  3.6 
Measured  ill  quadruplicate by 3-d cultures of aliquots of 2.5  x  104  line cells and  106 syngeneic 
accessory cells, obtained from the spleen and irradiated with 1,500 rad. The cells were cultured in 
the presence of 10 ug/ml of antigen or mitogen and  1% fresh autologous serum.  Line cells were 
tested for [3H]thymidine incorporation  17  d  after onset of primary culture, and showed 95-98% 
staining positivity for the W3/25 antigen at this time. ND, not done. 
* PPD, purified protein derivative of tuberculin. 
* This  high  degree  of proliferation  in  the  resting state  is  similar  to  that  observed  (47,  48),  on 
occasion, in other established rat T  cell lines. 
TABLE  IV 
Assessment of Knees Injected with Cell-derived Material Tested  for Ability to Bind Type H 
Collagen 
Culture  Affinity  Histologic 
Antigen  Donor  Strain  P 
Cell*  Stimulus  column  score* (n) 
Type I1  Arthritic  W-F  T  Type II  Type I1  4.1  +  0.3 (5)  0.001 
Type II  Arthritic  LIS  T  Type II  Type II  4.1  _+ 0.3 (4)  0.003 
Type II  Prearthritic  LOU-M  T  line  Type II  Type II  4.3 -+ 0.4 (6)  0.001 
Type II  Prearthritic  LOU-C  T  line  Type II  Type II  3.6 +  0.2 (6)  0.001 
Type II  Arthritic  W-F  T  Type II  Type I  1,6 -  0.5 (5)  NS 
Ovalbumin  Nonarthritic  LOU-M  T  line  Ovalbumin  Type II  1.4 _-_ 0.4 (6)  NS 
--  Naive  W-F  T  Con A  Type II  1.0 --- 0.6 (6)  -- 
Designations are identical to those described in Tables 1 and 1I. 
* Cell culture represents either nylon wool-purified T  cells or an aliquot of cells fi'om a  T  cell line 
obtained  17 (LOU-M) or 53 d  (LOU-C) after the onset of culture. 
* Derived from tissue samples 7  d  after injection of 100  ~tl of glycine-HCl eluate from the native 
collagen-Sepharose column. Protein concentrations in the eluates were <  0.1  mg/ml. 
postinjection detected abundant fibrin, and rare deposits of Ig and complement 
(C3).  Histologically,  the  synovitis  induced  in  the  knees  of  LOU  rats  by  the 
affinity-purified  AF was similar to that observed using G-100-enriched  material 
(Fig.  4).  Four knees of LOU-M  rats injected  25 d  earlier with affinity-purified, 
line cell-derived AF showed hyperplasia of the synovial lining, mononuclear cell 
infiltration,  subsynovial  fibrosis,  and  occasional  granulomas  (mean  histologic 
score +  SE, 3.6 +  0.3). 
Discussion 
These data demonstrate the existence of AF, a novel T  cell-derived artbrito- 
genic lymphokine,  in different strains of rats. At least a portion of this arthrito- 
genic  activity  is  antigen  binding,  and  the  ability  of native  type  II  collagen  to 
affinity  purify  AF  activity  suggests  that  the  responsible  species  is an  antigen- HELFGOTT  ET  AL.  1539 
FIGURE 2.  Analysis of AF by SDS-PAGE and  silver staining under  reducing conditions. 
Lanes represent  BS-peak I. A, AF-containing material derived from culturing nylon wool- 
enriched T cells from arthritic  LIS rats with type II collagen, diluted for application to the 
type II collagen-Sepharose column; B,  AF-containing material  generated  by the  type  II 
collagen-specific LOU-M T cell line, diluted for column application; C, diluted AF-containing 
material from the collagen-reactive LOU-C T cell line; D-F, CNBr peak 1 from the LIS, LOU- 
M, and LOU-C material, respectively;  G-l, CNBr peak II (glycine-HCI  eluate) from the LIS, 
LOU-M, and LOU-C material, respectively;  J, molecular mass standards. The linear streaks 
across the gel, including the one in the 60 kD region, are artifacts seen in similar gels run 
without protein application. 6-12 ~tg of protein was applied to lanes A-F, whereas lanes G-I 
each received <1  ttg. Development of this gel  was prolonged to  further  demonstrate  the 
absence of contaminating bands in lanes G-I. The analyzed CNBr peak II material from the 
W-F T cells also had a molecular mass of 65 kD. 
specific  lymphokine reactive  with  epitopes  on  type  II collagen.  The  ability  of 
puromycin  to  block  the  generation  of AF  activity  in  vitro  indicates  that  the 
protein is not preformed. Further analytic and functional characterization of AF 
is required to ascertain with greater certainty whether or not AF exists solely as 
a  single  65  kD  polypeptide  in  the  rat.  Additional  work  is  also  necessary  to 
determine  whether  the  bioactivity  of AF  crosses  strains  and/or  species,  or  is 
major histocompatibility complex-restricted. 
Most  studies  of antigen-specific  T  cell-derived  factors have  identified  those 
with suppressor properties (34,  35), however, analogous factors with promoting 
activities have been  detected  in  several  murine systems (36-38).  The ability of 
native,  but  not denatured,  type II collagen to stimulate  degrees of AF activity 
that  are  readily  detectable  by  bioassay  suggests  that  rat  T  cells  capable  of 
recognizing quarternary epitopes on collagen exist.  Previous studies in collagen 
arthritis have provided additional indirect evidence supporting this proposal (10, 
16).  Murine T  cells reactive with  conformationally dependent determinants on 
insulin  have  been  identified  recently by Glimcher et  al.  (39),  providing prece- 
dence for such a  phenomenon. 
Although  the  collagen-reactive  LOU-M  and  LOU-C  T  cell  lines  differed 1540  AN  ARTHRITOGENIC  LYMPHOKINE  IN  THE  RAT 
FIGURE  3.  Erosion of cartilage (arrow)  seen  48  h  after  injection of G-100-enriched  AF. 
(Original magnification, ×  200). 
markedly  in  their  ability  to  respond  in  vitro  to  native  type  II  collagen  by 
thymidine incorporation, both lines generated statistically similar degrees of AF 
activity.  This  finding  provides  evidence  that  the  capacity  to  proliferate  and 
produce lymphokines in response to antigen stimulation by various T  cell lines 
is dissociable, although the basis for this phenomenon is unclear. 
The molecular mass of AF differs from the ~20  kD protein, catabolin (40), 
which  stimulates  chondrocytes in  vitro,  nor  is  AF  identical  to  the  ~15  kD 
collagen-inducible cytokine, IL-1  or mononuclear cell factor, which heightens 
release of collagenase and prostaglandin E2 (PGE2) by cultured human synovial 
cells (I 7) and mediates cartilage matrix degradation (41). A substance, function- 
ally  equivalent  to  mononuclear  cell  factor  in  the  synoviocyte assay,  can  be 
generated in  rats by stimulating naive LNC with Con A, but its Mr by G-100 
filtration is 10,000-20,000 (C. E. Brinckerhoffand D. E. Trentham, unpublished 
data). Another difference from mononuclear cell factor is the inability of G-100 
fractionated AF to stimulate release of collagenase and PGE2 in the in vitro rat 
synoviocyte system (C.  E.  Brinckerhoff, S.  M.  Helfgott, and  D.  E.  Trentham, 
unpublished data). 
In  rats,  the  erosive joint  lesion  that  results  from  intravenous  injection  of 
affinity-purified collagen antibodies  has  been  reported (8)  to  be  complement- 
dependent, and to consist largely of polymorphonuclear leukocyte infiltration, 
rather  than  pannus  formation.  The  apparent  lack  of involvement  of blood 
complement and the mononuclear inflammatory cell preponderance in the AF- HELFGOTT  ET  AL.  1541 
FIGURE 4.  (a)  A  hypertrophied  and  inflamed synovium induced  by injecting (7  d  earlier) 
10 ~g of affinity-purified AF, generated by the type II collagen-specific LOU-M T  cell line, 
vs. (b) a normal rat knee synovium. (Original magnification, ×  400). 1542  AN  ARTHRITOGENIC I.YMPHOKINE IN  THE  RAT 
induced  lesion  make  it  unlikely  that  antibody  production  by the  recipient  ac- 
counts for the arthritogenic effect of AF. 
Although the initiation of collagen arthritis has been postulated (6, 7) to be an 
antibody-mediated event, the lesion produced by antibody is transient (6-8), and 
is incapable of being sustained by repeated injections (42). In contrast, a persistent 
arthritis characterized by extensive synovial hypertrophy can be induced by the 
intravenous  injection of collagen-sensitized spleen cells and  LNC in rats (4),  or 
by injection of nylon wool-purified T  cells in mice (5).  In the recipients of cells, 
no serum antibody response to collagen was detected (4, 5). These passive transfer 
experiments  may  indicate  that  cellular  immunity  plays  a  major  role  in  the 
pathogenesis of collagen arthritis.  The recognition of AF identifies a mechanism 
whereby this process could be subserved. 
Increasing attention is being directed to the role of T  cells in the pathogenesis 
of rheumatoid arthritis (1). Lymphokine-like moieties have been identified in the 
synovial fluid of patients with this disease (43). An inflammatory synovitis of the 
knee can  be induced  in  rabbits  by repeated  intraarticular  injections of culture 
supernatants  containing  factors  generated  by homologous  LNC  sensitized  to 
keyhole limpet hemocyanin (30).  The identification  of AF in an animal  model, 
and the presence of cellular sensitivity to collagen in patients  with rheumatoid 
arthritis  (44-46)  are  consistent  with  the hypothesis that  this  lymphokine  is an 
effector molecule in human synovial disease. 
Summary 
A  type II  collagen-specific arthritogenic  lymphokine  has  been  identified  in 
the rat. Arthritogenic factor (AF) is a 65 kD protein generated in vitro by T  cells 
from rats with collagen arthritis, and it induces an erosive, proliferative synovitis 
when  injected  into  the  knee joint  of syngeneic  naive  recipients.  Complement 
does not appear to be required. These data identify a potential T  cell-mediated 
effector mechanism  in  this  model,  and  suggest that  AF may function  in  other 
inflammatory synovial diseases. 
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